Multiple Sclerosis International Federation
Non-Profit & Charitable Organizations · United Kingdom · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
Skyline House, 200 Union Street Fl 3, Lo...Phone Number
+44 2076201911Website
www.msif.orgRevenue
$33.2 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Multiple Sclerosis International Federation
Founded in 1967 and headquartered in London, United Kingdom, the Multiple Sclerosis International Federation is an international body linking the activities of National MS societies around the world.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Multiple Sclerosis International Federation your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Multiple Sclerosis International Federation recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Multiple Sclerosis International Federation has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Multiple Sclerosis International Federation has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Multiple Sclerosis International Federation launches new products
Congratulate Masked Content for being promoted to Masked Content at Multiple Sclerosis International Federation
Multiple Sclerosis International Federation, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Multiple Sclerosis International Federation had a recent Job posting/layoffs
Check out if Multiple Sclerosis International Federation is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Multiple Sclerosis International Federation
Compare insights from companies similar to Multiple Sclerosis International Federation, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Multiple Sclerosis Intern...
$33.2M
501-1,000
Private
-
1967
N/A
Company Profile Activity
Activity Insights
Multiple Sclerosis International Federation is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Multiple Sclerosis International Federation is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Multiple Sclerosis International Federation.
Multiple Sclerosis International Federation Tech Stack
A closer look at the technologies used by Multiple Sclerosis International Federation
Multiple Sclerosis International Federation News & Media
Novartis presents new five-year data on disability outcomes and safety of Kesimpta® (ofatumumab) in people living with relapsing multiple sclerosis
The ALITHIOS open-label extension study showed continuous treatment with Kesimpta® (ofatumumab) for up to five years in relapsing multiple sclerosis (RMS) patients was associated with reduced risk of disability progression versus those who switched later from teriflunomide to Kesimpta1...On World Brain Day Join WFN, MSIF to Stop Multiple Sclerosis
July 22, 2021 is dedicated to raising awareness to improve the lives of those with multiple sclerosis and their caregivers LONDON, July 19, 2021 /PRNewswire/ -- On July 22, the World Federation of Neurology (WFN) and MS International Federation (MSIF) are leading the global World Brain...Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta® (ofatumumab) in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis
* New post hoc data from Phase III ASCLEPIOS trials showed newly diagnosed, treatment-naïve patients experienced reductions in annualized relapse rates, MRI lesion activity and reductions in time to disability worsening when treated with Kesimpta vs teriflunomide1 * Additional safety data in over 1,800 patients who continued Kesimpta treatment or switched therapy from previous studies reinforce the favorable safety profile of Kesimpta in patients with relapsing forms of multiple sclerosis (RMS)2
Read more news
Top Non-Profit & Charitable Organizations Companies
Frequently Asked Questions Regarding Multiple Sclerosis International Federation
Sign Up For FreeTo access detailed company insights
Founded in 1967 and headquartered in London, United Kingdom, the Multiple Sclerosis International Federation is an international body linking the activities of National MS societies around the world.... Read More
